MedTrace Logo

Population Health Management -Increase Lung Cancer Screening in Community Health Centers (LungSMART)

NCT07599943 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18894

Last updated 2026-05-20

No results posted yet for this study

Summary

The long-term goal of LungSMART Utah is to increase the reach of Low-Dose Computed Tomography (LDCT) screening for lung cancer (hereafter referred to as Lung Cancer Screening or LCS) at scale in low-resource healthcare settings.

Conditions

Interventions

BEHAVIORAL

Text Messages (TM+)

A message informs the participants that an RN from the Hub will call them about SDM and LCS.

BEHAVIORAL

Chatbot (CA)

Access to a chatbot for frequently asked questions about LCS

BEHAVIORAL

Video (VID)

An educational video about LCS

BEHAVIORAL

Reactive Patient Navigation (RPN)

RPN to help complete the LCS appointment. RPN requires the participant to initiate the PN request

BEHAVIORAL

Proactive Patient Navigation (PPN)

Proactive patient navigation to help complete the LCS appointment. PPN does not require the participant to initiate the PN request and instead is a proactive call to the participant.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Huntsman Cancer Institute

    collaborator OTHER

  • University of Utah

    lead OTHER

Principal Investigators

  • David Wetter, PhD, MS · Huntsman Cancer Institute/ University of Utah

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-08-31
Primary Completion
2030-04-30
Completion
2030-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07599943 on ClinicalTrials.gov